Invex Therapeutics Ltd Ordinary Shares IXC
Trading Information
- Previous Close Price
- A$0.11
- Day Range
- A$0.11–0.11
- 52-Week Range
- A$0.09–0.15
- Bid/Ask
- A$0.11 / A$0.11
- Shares Outstanding
- 75.15M
- Market Cap
- A$7.89M
- Volume/Avg
- 41,238 / 49,048
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Invex Therapeutics Ltd is a biopharmaceutical company focused on repurposing the approved drug Exenatide for the treatment of neurological conditions derived from or involving raised intracranial pressure, including Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. The Group's activities include the research and development of Exenatide, including pre-clinical research in Alzheimer's disease in collaboration with Tessara Therapeutics. It operates in one segment, comprising research and development activities within Australia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
Valuation
|
Metric
|
IXC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.02 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
IXC
Financial Strength
|
Metric
|
IXC
|
|---|---|
Quick Ratio | 26.48 |
Current Ratio | 26.48 |
Interest Coverage | — |
Quick Ratio
IXC
Profitability
|
Metric
|
IXC
|
|---|---|
Return on Assets (Normalized) | −28.46% |
Return on Equity (Normalized) | −29.60% |
Return on Invested Capital (Normalized) | −32.41% |
Return on Assets
IXC
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|n^%bf^> | LOCK|&^%@ | $129B | |||
| Moderna Inc
MRNA
| LOCK|ckVk@cj | LOCK|pS^ | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|S$psC$j | LOCK|n?<@ | $79B | |||
| argenx SE ADR
ARGX
| LOCK|xkV>>bz | LOCK|$% | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Q<b?Rv! | LOCK|&zx | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|cw><VM | LOCK|^>$V | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|t<W$WF> | LOCK|#P<c | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|rSK<@G | LOCK|FG | $24B | |||
| Incyte Corp
INCY
| LOCK|XTNv^s | LOCK|dvD | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|bPtQ>% | LOCK|?Rh | $14B |
United States